Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 15/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23258105 | 1.00 | ELANE (0.41) | ELANETSHRKDM4EHSD17B10TDP1 | |
| SCHEMBL25601308 | 0.90 | ELANE (0.45) | ELANE | |
| SCHEMBL22844652 | 0.89 | ELANE (0.41) | ELANETSHRALDH1A1HPGDNPSR1 | |
| SCHEMBL25607708 | 0.89 | ELANE (0.41) | ELANETSHRALDH1A1HPGDNPSR1 | |
| SCHEMBL25607704 | 0.89 | ELANE (0.41) | ELANETSHRALDH1A1HPGDNPSR1 | |
| SCHEMBL22844659 | 0.89 | ELANE (0.41) | ELANETSHRALDH1A1HPGDNPSR1 | |
| SCHEMBL22844646 | 0.86 | ELANE (0.35) | ELANETSHRKDM4EHSD17B10TDP1 | |
| SCHEMBL10668491 | 0.84 | ELANE (0.40) | ELANE | |
| SCHEMBL22844653 | 0.84 | ELANE (0.37) | ELANE | |
| SCHEMBL25607706 | 0.84 | ELANE (0.37) | ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230173079-A1 | Conjugate Molecules | DIVERSE BIOTECH, INC. (US) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230173079-A1 | Conjugate Molecules | CNR2, CNR1, MAG | ELANE 1747/4885TSHR 3475/4885KDM4E 1418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.